Inhaled loxapine is indicated for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder.
Rapid Review
| Commenced | Completed | Outcome |
| 21/06/2016 | 28/07/2016 | Full Pharmacoeconomic Evaluation Recommended |
Not considered cost-effective due to non-submission of full pharmacoeonomic evaluation